Affinity Asset Advisors, LLC

SEC CIK: 0001773195
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

DYN holding history

Dyne Therapeutics, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DYN overview All 13F holders of DYN Full Q2 2026 holdings

Shares (Q3 2024): 0; Sold out in Q3 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2022

Holdings of DYN by Affinity Asset Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2024	0	$0	0.0%	−100,000−100.0%	Sold out	Holders
Q2 2024	100,000	$3.53M	0.6%	+100,000	New	Holders
Q1 2023	0	$0	0.0%	−92,170−100.0%	Sold out	Holders
Q4 2022	92,170	$1.07M	0.5%	+92,170	New	Holders